This wouldn't be Kodak's first attempt at pharmaceuticals, but the company's track record has critics questioning the arrangement for the $765 million U.S. government loan to make ingredients for generic drugs.
source https://www.seattletimes.com/business/kodak-pivots-to-drugs-after-abandoning-photography-crypto/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_technology
No comments:
Post a Comment